OCS products based on exosome technology
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OCS products based on exosome technology, covering 2025-09-04 to 2025-09-04. Get the full timeline:
Most recent: Clinical Trial Update: OCS Products Based on Exosome Technology Were Applied in the Recurrence Monitoring Study After the Initial Treatment of Baseline CA125-negative Ovarian Cancer